Skip to main content
Toggle navigation
Search
Home
Icon Legend
Food/Drinks Available
CE's Available
Reception
Pre-registration Required
Livestreaming
Recorded Session
Back
Workshop
PTAC/CFTR
EPP
Session: W36--Genetic & Cell-Based Approaches to CF Therapy
W36.2-
SPL
84-23
-1 Antisense Oligonucleotide
Modulating the 3849+10kb C-T Splicing Defect, Has an Additive Effect with TRIKAFTA in Primary HBE Cells from 3849 Patients
Saturday, November 5, 2022
3:30 PM – 5:30 PM
ET
Location: 118 ABC
Speaker(s)
Efrat Ozeri Galai
SpliSense Ltd., Jerusalem, Israel